Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
A research study of DCVax®-L in subjects with Glioblastoma Multiforme. The purpose of this clinical trial is to determine whether DCVax®-L can slow the growth and recurrence of a brain tumor and whether it can extend overall survival. Other goals of this trial are to test the safety and activity of DCVax®-L and to determine whether the study agent causes an immune response against cancer cells
as compared to standard treatment or another experimental treatment.